Phase II study of mitoxantrone in patients with mesothelioma: a National Cancer Institute of Canada Clinical Trials Group Study
Eisenhauer, E.A.; Evans, W.K.; Raghavan, D.; Desmeules, M.J.; Murray, N.R.; Stuart-Harris, R.; Wilson, K.S.
Cancer Treatment Reports 70(8): 1029-1030
1986
ISSN/ISBN: 0361-5960 PMID: 3731150 Document Number: 275938
Document emailed within 1 workday
Related Documents
Evans, W.K.; Coyle, D.; Gafni, A.; Walker, H. 2003: Which cancer clinical trials should be considered for economic evaluation? Selection criteria from the National Cancer Institute of Canada's Working Group on Economic Analysis Chronic diseases in Canada 24(4): 102-107van Breukelen, F.J.; Mattson, K.; Giaccone, G.; van Zandwijk, N.; Planteydt, H.T.; Kirkpatrick, A.; Dalesio, O. 1991: Mitoxantrone in malignant pleural mesothelioma: a study by the EORTC Lung Cancer Cooperative Group European Journal of Cancer 27(12): 1627-1629
Levin, M.; Pandya, K.J.; Khandekar, J.D.; Horton, J.; Glick, J.H.; Bennett, J.M.; Muggia, F.M.; Falkson, G. 1984: Phase Ii study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study Cancer Treatment Reports 68(12): 1511-1512
Taylor, S.A.; Von Hoff, D.D.; Baker, L.H.; Balcerzak, S.P. 1984: Phase Ii clinical trial of mitoxantrone in patients with advanced renal cell carcinoma: a Southwest Oncology Group study Cancer Treatment Reports 68(6): 919-920
Davis, R.B.; Van Echo, D.A.; Leone, L.A.; Henderson, E.S. 1986: Phase Ii trial of mitoxantrone in advanced primary liver cancer: a Cancer and Leukemia Group B Study Cancer Treatment Reports 70(9): 1125-1126
Ettinger, D.S.; Finkelstein, D.M.; Harper, G.R.; Ruckdeschel, J.C.; Chang, A.Y.; Camacho, F.J.; Marsh, J.C.; Silber, R.; Wolter, J.M. 1985: Phase Ii study of mitoxantrone, aclarubicin, and diaziquone in the treatment of non-small cell lung carcinoma: an Eastern Cooperative Oncology Group study Cancer Treatment Reports 69(9): 1033-1034
Sakata, Y.; Shimada, Y.; Yoshino, M.; Kambe, M.; Futatsuki, K.; Nakao, I.; Ogawa, N.; Wakui, A.; Taguchi, T. 1994: A late phase II study of CPT-11, irinotecan hydrochloride, in patients with advanced pancreatic cancer. CPT-11 Study Group on Gastrointestinal Cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 21(7): 1039-1046
Amrein, P.C.; Coleman, M.; Richards, F.; Poulin, R.F.; Bernhardt, B.; Ginsberg, S.J.; Green, M.R.; Morrison, A.; Cortes, E.; Kiang, D.; Weinberg, V.; Wood, W.C. 1982: Phase Ii study of AMSA in patients with metastatic breast cancer: a Cancer and Leukemia Group B study Cancer Treatment Reports 66(5): 1211-1213
Avent, R.; Birch, R.; Oldham, R.K.; Arnold, J. 1990: Successful clinical trials in the private sector: the National Biotherapy Study Group (NBSG) experience Progress in Clinical and Biological Research 339: 419-423
Ivy, S.Percy.; Ivy, S.Percy. 2015: The National Cancer Institute's Experimental Therapeutics Clinical Trials Network Clinical Advances in Hematology and Oncology: H&o 13(3): 144-146
Hoyt, D.B.; Holcomb, J.; Abraham, E.; Atkins, J.; Sopko, G. 2004: Working Group on Trauma Research Program summary report: National Heart Lung Blood Institute (NHLBI), National Institute of General Medical Sciences (NIGMS), and National Institute of Neurological Disorders and Stroke (NINDS) of the National Institutes of Health (NIH), and the Department of Defense (DOD) Journal of trauma 57(2): 410-415
Yokoyama, A.; Nakai, Y.; Yoneda, S.; Kurita, Y.; Niitani, H.; Taguchi, T. 1996: A late phase Ii study of LY188011 (Gemcitabine hydrochloride) in patients with non-small-cell lung cancer. Gemcitabine Cooperative Study Group B for Late Phase Ii Gan to Kagaku Ryoho. Cancer and ChemoTherapy 23(12): 1681-1688
Ogawa, M.; Kubo, K.; Tominaga, T.; Nomura, Y.; Ota, K.; Yoshida, M.; Taguchi, T.; Hoshino, A. 1986: Phase Ii study of mitoxantrone in advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 13(5): 1980-1984
Sugihara, K.; Auther, C.; Mori, S.; Nishihira, T.; Matsumoto, T.; Kawachi, S.; Ishikawa, M.; Takahashi, M.; Nakajima, T.; Kosaki, G. 1990: Early phase Ii study of the combined use of AO-90 methionine-free amino acid solution and anticancer agents (5-FU and MMC) in patients with advanced and recurrent gastrointestinal cancer. AO-90 Study group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 17(12): 2405-2413
Taguchi, T.; Wakui, A.; Nabeya, K.; Kurihara, M.; Isono, K.; Kakegawa, T.; Ota, K. 1992: A phase Ii clinical study of cis-diammine glycolato platinum, 254-S, for gastrointestinal cancers. 254-S Gastrointestinal Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 19(4): 483-488
Kosmidis, P.A.; Samantas, E.; Fountzilas, G.; Pavlidis, N.; Apostolopoulou, F.; Skarlos, D. 1994: Cisplatin/etoposide versus carboplatin/etoposide chemotherapy and irradiation in small cell lung cancer: a randomized phase IIi study. Hellenic Cooperative Oncology Group for Lung Cancer Trials Seminars in Oncology 21(3 Suppl 6: 23-30
DeSimone, P.A.; Gams, R.; Bartolucci, A. 1986: Weekly mitoxantrone in the treatment of advanced pancreatic carcinoma: a Southeastern Cancer Study Group Trial Cancer Treatment Reports 70(7): 929-930
Shimoyama, M.; Tajima, K. 1993: Japan Clinical Oncology Group for cooperative cancer clinical trials and role of the statistical center in the management of cancer clinical trials Gan to Kagaku Ryoho. Cancer and ChemoTherapy 20(16): 2507-2518
Nomura, Y.; Abe, O.; Enomoto, K.; Fujiwara, K.; Tominaga, T.; Hayashi, K.; Uchino, J.; Takahashi, M.; Hayasaka, A.; Asaishi, K.; Okazaki, M.; Abe, R.; Kimishima, I.; Kajiwara, T.; Haga, S.; Shimizu, T.; Miyazaki, I.; Noguchi, M.; Yoshida, M.; Miura, S.; Taguchi, T.; Oota, J.; Sakai, K.; Kinoshita, H.; Tashiro, H. 1998: Phase i study of TAT-59 (a new antiestrogen) in breast cancer. TAT-59 Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 25(4): 553-561
Taguchi, T.; Koyama, H.; Yayoi, K.; Wada, T.; Takatsuka, Y.; Sonoo, H.; Morimoto, K.; Tominaga, T.; Abe, R.; Enomoto, K. 1995: Long-term clinical study on TAP-144-SR, an LH-RH agonist depot formulation, in premenopausal patients with advanced or recurrent breast cancer. TAP-144-SR Breast Cancer Study Group Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 495-508